This article provides a game theory and law-and-management analysis of forprofit pharmaceutical public-private partnerships, a complex type of legal arrangement in the highly regulated pharmaceutical industry.
This article describes the construct of “legal astuteness” and explains why it is a valuable dynamic capability. It also examines the systems approach to law and strategy, which embeds the top management team within the firm’s “ecosystem.”
I postulate that “legal astuteness” is a valuable managerial capability that may provide a competitive advantage under the resource-based view of the firm. Law and the tools it offers are an enabling force legally astute management teams can use to manage the firm more effectively.
Reconstructing the role of the Chief Legal Officer and the corporate client in a globalizing world.
Co-authored with Bruce F. Freed and Karl J. Sandstrom
Featured in “Harvard Business Review” (co-authored with Bruno Cova and Lee D. Augsburger)
Replacing Corporate Directors’ Veil of Secrecy with the Mantle of Stewardship Featured in the “San Diego Law Review” (Co-authored with Karen L. Page)
The Risk Companies Face When Their Political Spending and Core Values Conflict and How to Address Them
A Multi-Prong Proposal to Develop Counter-measures for Chemical, Biological, Radiological, and Nuclear Threats Co-Authored by Anat Alon-Beck